Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Waldron-Lynch

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Medical Genetics|June 4, 1998
Exclusion of the familial Mediterranean fever locus as a susceptibility region for autosomal dominant familial Hibernian feverM F McDermott, E M McDermott, K A Quane, et al.
Diabetologia|October 23, 2012
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trialK C Herold, S E Gitelman, S M Willi, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Medical Genetics|June 4, 1998
Exclusion of the familial Mediterranean fever locus as a susceptibility region for autosomal dominant familial Hibernian feverM F McDermott, E M McDermott, K A Quane, et al.
Diabetologia|October 23, 2012
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trialK C Herold, S E Gitelman, S M Willi, et al.
Pageof 2